MS Therapeutics Market to 2019 – Treatment Diversification and Pipeline Innovation to Drive Growth, Says a New Report at RnRMarketResearch.com http://www.digitaljournal.com/pr/1454963#ixzz2eORw5d8P
http://www.digitaljournal.com/pr/1454963


Multiple Sclerosis Therapeutics Market to 2019 – Treatment Diversification and Pipeline...
www.digitaljournal.com
Dallas, Texas (PRWEB) September 08, 2013 The global multiple sclerosis therapeutics market has the potential to grow to a value of $17.9 billion by 2019. The market is currently led by Copaxone, which achieved global sales of $4 billion in 2012. Over the forecast period 2012–2019, a variety of new d...